NewAmsterdam Pharma Warrant

NAMSW

Börsenwert 50,6 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Frazier Life Sciences Management Palo Alto, California	5,52 Mio. $	–	–	–
2	2 RA Capital Management Boston, Massachusetts	3,68 Mio. $	–	–	–
3	3 Affinity Asset Advisors New York	2,24 Mio. $	+596.603 $	+65.599	+48 %
4	4 GTS Securities Miami, Florida	1,34 Mio. $	+1,1 Mio. $	+121.150	Neu
5	5 Bain Capital Life Sciences Investors Boston, Massachusetts	1,1 Mio. $	–	–	–
6	6 Deerfield Management New York	1,02 Mio. $	–	–	–
7	7 Monashee Investment Management Boston, Massachusetts	344.327 $	+283.655 $	+31.189	Neu
8	8 HRT Financial New York	334.000 $	–	–	–
9	9 Laurion Capital Management New York	183.993 $	–	–	–
10	10 Vestcor Inc Fredericton, New Brunswick, Canada	106.000 $	–	–	–
11	11 CIBC Private Wealth Group Atlanta, Georgia	11.285 $	+9.095 $	+1.000	Neu
12	12 Ensign Peak Advisors Salt Lake City, Utah	–	-469.500 $	-150.000	Geschlossen
13	13 ADAR1 Capital Management Austin, Texas	–	-259.342 $	-82.857	Geschlossen
14	14 EcoR1 Capital San Francisco, California	–	-744.648 $	-66.665	Geschlossen
15	15 Westchester Capital Management (New York) Valhalla, New York	–	-97.622 $	-31.189	Geschlossen
16	16 Walleye Capital New York	–	-70.920 $	-22.658	Geschlossen
17	17 Susquehanna International Group Bala Cynwyd, Pennsylvania	–	-57.338 $	-18.319	Geschlossen
18	18 PEAK6 Investments Chicago, Illinois	–	-53.210 $	-17.000	Geschlossen
19	19 Walleye Trading New York	–	-40.953 $	-13.084	Geschlossen
20	20 Clear Street New York	–	-28.148 $	-8.993	Geschlossen
21	CG 21 Cutler Group San Francisco, California	–	-15.000 $	-4.960	Geschlossen

NewAmsterdam Pharma Warrant NAMSW Börsenwert 50,6 Mio. $

NewAmsterdam Pharma Warrant

NAMSW

Börsenwert 50,6 Mio. $